While among those with CC/CT genotypes of the ALDH2 rs10744777, the carriers of the BRCA2 p.K3326* mutation did not have a higher risk of breast cancer compared to non-carriers (OR = 1.05, 95% CI: 0.73–1.51, P = 0.81) [30]. This evidence concerns the gene BRCA2 and breast carcinoma.